Integrated US-MR fusion images and MR targeted biopsies. What are their role and value in the detection and follow-up of prostate cancer - Abstract

Accuracy of multiparametric MRI has greatly improved the ability of localizing tumor foci of prostate cancer.

This property can be used to perform a TRUS-MR image registration, new technological advance, which allows for an overlay of an MRI onto a TRUS image to target a prostate biopsy toward a suspicious area Three types of registration have been developed: cognitive-based, sensor-based, and organ-based registration. Cognitive registration consists of aiming a suspicious area during biopsy with the knowledge of the lesion location identified on multiparametric MRI. Sensor-based registration consists of tracking in real time the TRUS probe with a magnetic device, achieving a global positioning system which overlays in real-time prostate image on both modalities. Organ based registration does not aim to track the TRUS probe, but the prostate itself to compute in a 3D acquisition the TRUS prostate shape, allowing for a registration with the corresponding 3D MRI shape. The concept of an MR-US fusion TB strategy only is gaining more and more widespread acceptance. In a TB only strategy, fewer men could be biopsied overall, with a greater proportion of men diagnosed with clinically significant prostate, as well as fewer men "over diagnosed" with clinically insignificant cancer. However, more clinical research is required before this strategy is ready for widespread adoption.

Written by:
Delongchamps NB, Escourou C, Cornud F.   Are you the author?
Department of Urology, Cochin Hospital, Paris Descartes University, Paris, France.

Reference: Arch Esp Urol. 2015 Apr;68(3):349-353.


PubMed Abstract
PMID: 25948805

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe